HONG KONG, May 13, 2021 - (ACN Newswire) - China Shineway Pharmaceutical Group Limited (2877.HK) recently released its unaudited turnover for the three months ended 31 March 2021 (Q1 2021) based on its management accounts.

Revenue for Q1 2021 went up 37.0% YoY, which implies a growth of 20.4% over the pre-COVID 19 levels, as compared with the...